Recordati in the world - Europe
GreeceRomaniaSpainSwitzerlandTurkeyCzech RepublicPortugalTunisiaUkraineFranceGermanyIrelandItalyPolandRussia and C.I.S.United KingdomAustriaSwedenBeneluxBulgaria
Jan Stenbecks Torg  17 
S - 16440 Kista, Sweden
Ph. +46 8 545 80 230
Fax +46 8 660 50 78

Specialty and Primary Care Nordic countries:

Rare diseases Nordic and Baltic countries:
Recordati’s primary and specialty care operations are present in the Czech Republic and Slovakia, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Romania, Russia and C.I.S., Spain, Switzerland, Turkey, Tunisia and the United Kingdom. Recordati’s operations dedicated to treatments for rare diseases have worldwide coverage: Europe, the Middle East, U.S.A., Canada, Mexico, some South American countries, Malaysia and Japan.  Recordati markets both proprietary products as well as innovative drugs under license from the originating pharmaceutical companies.

Thanks to numerous licensing agreements with international pharmaceutical companies, Recordati's proprietary pharmaceuticals are distributed in more than 100 countries.